Human Gene KCNQ2 (ENST00000359125.7_10) from GENCODE V47lift37
  Description: potassium voltage-gated channel subfamily Q member 2, transcript variant 1 (from RefSeq NM_172107.4)
Gencode Transcript: ENST00000359125.7_10
Gencode Gene: ENSG00000075043.21_21
Transcript (Including UTRs)
   Position: hg19 chr20:62,031,561-62,104,008 Size: 72,448 Total Exon Count: 17 Strand: -
Coding Region
   Position: hg19 chr20:62,037,997-62,103,816 Size: 65,820 Coding Exon Count: 17 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviewsModel Information
Methods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr20:62,031,561-62,104,008)mRNA (may differ from genome)Protein (872 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCHuman Cortex Gene ExpressionMalacardsMGIOMIMPubMed
ReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: KCNQ2_HUMAN
DESCRIPTION: RecName: Full=Potassium voltage-gated channel subfamily KQT member 2; AltName: Full=KQT-like 2; AltName: Full=Neuroblastoma-specific potassium channel subunit alpha KvLQT2; AltName: Full=Voltage-gated potassium channel subunit Kv7.2;
FUNCTION: Probably important in the regulation of neuronal excitability. Associates with KCNQ3 to form a potassium channel with essentially identical properties to the channel underlying the native M-current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons as well as the responsiveness to synaptic inputs. KCNQ2/KCNQ3 current is blocked by linopirdine and XE991, and activated by the anticonvulsant retigabine. Muscarinic agonist oxotremorine-M strongly suppress KCNQ2/KCNQ3 current in cells in which cloned KCNQ2/KCNQ3 channels were coexpressed with M1 muscarinic receptors.
SUBUNIT: Heteromultimer with KCNQ3. May associate with KCNE2.
SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
TISSUE SPECIFICITY: In adult and fetal brain. Highly expressed in areas containing neuronal cell bodies, low in spinal chord and corpus callosum. Isoform 2 is preferentially expressed in differentiated neurons. Isoform 6 is prominent in fetal brain, undifferentiated neuroblastoma cells and brain tumors.
DOMAIN: The segment S4 is probably the voltage-sensor and is characterized by a series of positively charged amino acids at every third position (By similarity).
PTM: In Xenopus oocytes KCNQ2/KCNQ3 heteromeric current can be increased by intracellular cyclic AMP, an effect that depends on phosphorylation of Ser-52 in the N-terminus region.
DISEASE: Defects in KCNQ2 are the cause of benign familial neonatal seizures type 1 (BFNS1) [MIM:121200]. A disorder characterized by clusters of seizures occurring in the first days of life. Most patients have spontaneous remission by 12 months of age and show normal psychomotor development. Some rare cases manifest an atypical severe phenotype associated with epileptic encephalopathy and psychomotor retardation. The disorder is distinguished from benign familial infantile seizures by an earlier age at onset. In some patients, neonatal convulsions are followed later in life by myokymia, a benign condition characterized by spontaneous involuntary contractions of skeletal muscles fiber groups that can be observed as vermiform movement of the overlying skin. Electromyography typically shows continuous motor unit activity with spontaneous oligo- and multiplet- discharges of high intraburst frequency (myokymic discharges). Some patients may have isolated myokymia.
DISEASE: Defects in KCNQ2 are the cause of epileptic encephalopathy early infantile type 7 (EIEE7) [MIM:613720]. EIEE7 is an autosomal dominant seizure disorder characterized by infantile onset of refractory seizures with resultant delayed neurologic development and persistent neurologic abnormalities.
MISCELLANEOUS: Inclusion of isoform 6 in heteromultimers results in attenuation of potassium current. Prominent expression of isoform 6 in the developing brain may alter firing repertoires of immature neurons excitability to provide cues for proliferation rather than differentiation.
MISCELLANEOUS: Mutagenesis experiments were carried out in Xenopus oocytes by coexpression of either KCNQ2(mut) and KCNQ3 at the ratio of 1:1, or of KCNQ2(mut), KCNQ2(wt) and KCNQ3 at the ratio of 1:1:2, to mimic the situation in a heterozygous patient with BFNC1 disease.
SIMILARITY: Belongs to the potassium channel family. KQT (TC 1.A.1.15) subfamily. Kv7.2/KCNQ2 sub-subfamily.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/KCNQ2";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: KCNQ2
Diseases sorted by gene-association score: epileptic encephalopathy, early infantile, 7* (1581), seizures, benign neonatal, 1* (1200), benign familial neonatal epilepsy* (776), benign neonatal seizures* (450), seizure disorder* (418), benign epilepsy with centrotemporal spikes* (415), centrotemporal epilepsy* (400), convulsions benign familial neonatal dominant form* (400), seizures, benign neonatal, type 2* (283), west syndrome* (236), epileptic encephalopathy, early infantile, 1* (231), epileptic encephalopathy, early infantile, 15* (209), visual epilepsy* (179), benign familial infantile epilepsy* (164), kcnq2-related disorders* (100), idiopathic generalized epilepsy (14), neonatal period electroclinical syndrome (14), infancy electroclinical syndrome (10), epilepsy, nocturnal frontal lobe, 1 (8), generalized epilepsy with febrile seizures plus (8), childhood electroclinical syndrome (7), epileptic encephalopathy, childhood-onset (7), epilepsy (6), epileptic encephalopathy, early infantile, 9 (5), pontocerebellar hypoplasia, type 6 (5), lennox-gastaut syndrome (5), epileptic encephalopathy, early infantile, 6 (5), glycine encephalopathy (4), neuroblastoma (4), long qt syndrome (3)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene
  • D013793 Thallium
  • C112297 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone
  • D020106 Acrylamide
  • C476437 N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide
  • C576869 (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide
  • C111118 2',3,3',4',5-pentachloro-4-hydroxybiphenyl
  • C030370 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone
  • D015122 6-Mercaptopurine
  • D000082 Acetaminophen
  • D000643 Ammonium Chloride
          more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 29.54 RPKM in Brain - Cerebellum
Total median expression: 193.58 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -113.40192-0.591 Picture PostScript Text
3' UTR -2981.206436-0.463 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR020969 - Ankyrin-G_BS
IPR005821 - Ion_trans_dom
IPR003091 - K_chnl
IPR003937 - K_chnl_volt-dep_KCNQ
IPR003947 - K_chnl_volt-dep_KCNQ2
IPR013821 - K_chnl_volt-dep_KCNQ_C

Pfam Domains:
PF00520 - Ion transport protein
PF03520 - KCNQ voltage-gated potassium channel
PF07885 - Ion channel
PF11956 - Ankyrin-G binding motif of KCNQ2-3
PF16642 - Unstructured region on Potassium channel subunit alpha KvLQT2

SCOP Domains:
81324 - Voltage-gated potassium channels

ModBase Predicted Comparative 3D Structure on O43526
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005216 ion channel activity
GO:0005244 voltage-gated ion channel activity
GO:0005249 voltage-gated potassium channel activity
GO:0005267 potassium channel activity
GO:0005515 protein binding
GO:0005516 calmodulin binding
GO:0030506 ankyrin binding

Biological Process:
GO:0006811 ion transport
GO:0006813 potassium ion transport
GO:0007268 chemical synaptic transmission
GO:0007399 nervous system development
GO:0034765 regulation of ion transmembrane transport
GO:0055085 transmembrane transport
GO:0071805 potassium ion transmembrane transport

Cellular Component:
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0008076 voltage-gated potassium channel complex
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0033268 node of Ranvier
GO:0043194 axon initial segment


-  Descriptions from all associated GenBank mRNAs
  Y15065 - Homo sapiens mRNA for voltage gated potassium channel.
BC020384 - Homo sapiens potassium voltage-gated channel, KQT-like subfamily, member 2, mRNA (cDNA clone IMAGE:4154700).
JD356989 - Sequence 338013 from Patent EP1572962.
JD536882 - Sequence 517906 from Patent EP1572962.
JD461484 - Sequence 442508 from Patent EP1572962.
JD456709 - Sequence 437733 from Patent EP1572962.
JD228566 - Sequence 209590 from Patent EP1572962.
JD546390 - Sequence 527414 from Patent EP1572962.
JD220431 - Sequence 201455 from Patent EP1572962.
JD540784 - Sequence 521808 from Patent EP1572962.
JD208315 - Sequence 189339 from Patent EP1572962.
JD078904 - Sequence 59928 from Patent EP1572962.
BC127262 - Homo sapiens cDNA clone IMAGE:40128664.
JD213716 - Sequence 194740 from Patent EP1572962.
JD334849 - Sequence 315873 from Patent EP1572962.
JD166484 - Sequence 147508 from Patent EP1572962.
JD108732 - Sequence 89756 from Patent EP1572962.
JD353727 - Sequence 334751 from Patent EP1572962.
JD384515 - Sequence 365539 from Patent EP1572962.
JD102526 - Sequence 83550 from Patent EP1572962.
JD222112 - Sequence 203136 from Patent EP1572962.
JD226907 - Sequence 207931 from Patent EP1572962.
JD230391 - Sequence 211415 from Patent EP1572962.
JD109095 - Sequence 90119 from Patent EP1572962.
JD453466 - Sequence 434490 from Patent EP1572962.
JD246623 - Sequence 227647 from Patent EP1572962.
JD223635 - Sequence 204659 from Patent EP1572962.
JD495796 - Sequence 476820 from Patent EP1572962.
JD329950 - Sequence 310974 from Patent EP1572962.
JD322721 - Sequence 303745 from Patent EP1572962.
JD246623 - Sequence 227647 from Patent EP1572962.
JD036914 - Sequence 17938 from Patent EP1572962.
JD335717 - Sequence 316741 from Patent EP1572962.
JD445250 - Sequence 426274 from Patent EP1572962.
JD532582 - Sequence 513606 from Patent EP1572962.
JD057268 - Sequence 38292 from Patent EP1572962.
JD037170 - Sequence 18194 from Patent EP1572962.
JD440643 - Sequence 421667 from Patent EP1572962.
JD422422 - Sequence 403446 from Patent EP1572962.
JD200372 - Sequence 181396 from Patent EP1572962.
JD156900 - Sequence 137924 from Patent EP1572962.
JD200139 - Sequence 181163 from Patent EP1572962.
JD341727 - Sequence 322751 from Patent EP1572962.
JD354306 - Sequence 335330 from Patent EP1572962.
JD082239 - Sequence 63263 from Patent EP1572962.
JD297934 - Sequence 278958 from Patent EP1572962.
JD118890 - Sequence 99914 from Patent EP1572962.
JD450037 - Sequence 431061 from Patent EP1572962.
JD549310 - Sequence 530334 from Patent EP1572962.
JD226326 - Sequence 207350 from Patent EP1572962.
JD231209 - Sequence 212233 from Patent EP1572962.
JD047272 - Sequence 28296 from Patent EP1572962.
JD443909 - Sequence 424933 from Patent EP1572962.
JD051550 - Sequence 32574 from Patent EP1572962.
JD450928 - Sequence 431952 from Patent EP1572962.
JD534266 - Sequence 515290 from Patent EP1572962.
JD098061 - Sequence 79085 from Patent EP1572962.
JD534279 - Sequence 515303 from Patent EP1572962.
JD097253 - Sequence 78277 from Patent EP1572962.
JD317228 - Sequence 298252 from Patent EP1572962.
JD050492 - Sequence 31516 from Patent EP1572962.
JD050662 - Sequence 31686 from Patent EP1572962.
JD101143 - Sequence 82167 from Patent EP1572962.
JD370077 - Sequence 351101 from Patent EP1572962.
JD049849 - Sequence 30873 from Patent EP1572962.
JD512430 - Sequence 493454 from Patent EP1572962.
JD051437 - Sequence 32461 from Patent EP1572962.
JD377831 - Sequence 358855 from Patent EP1572962.
JD050671 - Sequence 31695 from Patent EP1572962.
JD350910 - Sequence 331934 from Patent EP1572962.
JD475487 - Sequence 456511 from Patent EP1572962.
JD537007 - Sequence 518031 from Patent EP1572962.
JD536307 - Sequence 517331 from Patent EP1572962.
JD439300 - Sequence 420324 from Patent EP1572962.
JD225979 - Sequence 207003 from Patent EP1572962.
JD114821 - Sequence 95845 from Patent EP1572962.
JD185565 - Sequence 166589 from Patent EP1572962.
JD103175 - Sequence 84199 from Patent EP1572962.
JD050672 - Sequence 31696 from Patent EP1572962.
JD431433 - Sequence 412457 from Patent EP1572962.
JD201574 - Sequence 182598 from Patent EP1572962.
JD057502 - Sequence 38526 from Patent EP1572962.
JD377849 - Sequence 358873 from Patent EP1572962.
JD504633 - Sequence 485657 from Patent EP1572962.
JD211575 - Sequence 192599 from Patent EP1572962.
JD547326 - Sequence 528350 from Patent EP1572962.
JD097145 - Sequence 78169 from Patent EP1572962.
JD130419 - Sequence 111443 from Patent EP1572962.
JD519250 - Sequence 500274 from Patent EP1572962.
JD320104 - Sequence 301128 from Patent EP1572962.
JD361734 - Sequence 342758 from Patent EP1572962.
JD533190 - Sequence 514214 from Patent EP1572962.
JD318633 - Sequence 299657 from Patent EP1572962.
JD088162 - Sequence 69186 from Patent EP1572962.
JD191243 - Sequence 172267 from Patent EP1572962.
JD121954 - Sequence 102978 from Patent EP1572962.
JD322813 - Sequence 303837 from Patent EP1572962.
JD173098 - Sequence 154122 from Patent EP1572962.
JD204534 - Sequence 185558 from Patent EP1572962.
JD540133 - Sequence 521157 from Patent EP1572962.
JD393062 - Sequence 374086 from Patent EP1572962.
JD232478 - Sequence 213502 from Patent EP1572962.
JD464889 - Sequence 445913 from Patent EP1572962.
JD466202 - Sequence 447226 from Patent EP1572962.
JD403396 - Sequence 384420 from Patent EP1572962.
JD464266 - Sequence 445290 from Patent EP1572962.
JD266409 - Sequence 247433 from Patent EP1572962.
AF033348 - Homo sapiens potassium channel (KCNQ2) mRNA, complete cds.
AF074247 - Homo sapiens neuronal delayed-rectifier voltage-gated potassium channel splice variant (KCNQ2) mRNA, complete cds.
JD045524 - Sequence 26548 from Patent EP1572962.
JD045470 - Sequence 26494 from Patent EP1572962.
JD513827 - Sequence 494851 from Patent EP1572962.
JD463573 - Sequence 444597 from Patent EP1572962.
JD372983 - Sequence 354007 from Patent EP1572962.
JD475912 - Sequence 456936 from Patent EP1572962.
AF110020 - Homo sapiens potassium channel (KCNQ2) mRNA, complete cds.
JD133237 - Sequence 114261 from Patent EP1572962.
JD278527 - Sequence 259551 from Patent EP1572962.
BC146294 - Synthetic construct Homo sapiens clone IMAGE:100015254, MGC:180270 potassium voltage-gated channel, KQT-like subfamily, member 2 (KCNQ2) mRNA, encodes complete protein.
AB527167 - Synthetic construct DNA, clone: pF1KB7330, Homo sapiens KCNQ2 gene for potassium voltage-gated channel, KQT-like subfamily, member 2, without stop codon, in Flexi system.
AK293727 - Homo sapiens cDNA FLJ60440 complete cds, highly similar to Potassium voltage-gated channel subfamily KQT member 2.
D82346 - Homo sapiens mRNA for HNSPC, complete cds.
BC000699 - Homo sapiens potassium voltage-gated channel, KQT-like subfamily, member 2, mRNA (cDNA clone IMAGE:3349625), complete cds.
BT007043 - Homo sapiens potassium voltage-gated channel, KQT-like subfamily, member 2 mRNA, complete cds.
KJ891510 - Synthetic construct Homo sapiens clone ccsbBroadEn_00904 KCNQ2 gene, encodes complete protein.
KR710741 - Synthetic construct Homo sapiens clone CCSBHm_00016415 KCNQ2 (KCNQ2) mRNA, encodes complete protein.
KR710742 - Synthetic construct Homo sapiens clone CCSBHm_00016416 KCNQ2 (KCNQ2) mRNA, encodes complete protein.
KR710743 - Synthetic construct Homo sapiens clone CCSBHm_00016430 KCNQ2 (KCNQ2) mRNA, encodes complete protein.
AY358189 - Homo sapiens clone DNA139669 KCNQ2 (UNQ6166) mRNA, complete cds.
JD461997 - Sequence 443021 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_raccPathway - Ion Channels and Their Functional Role in Vascular Endothelium

Reactome (by CSHL, EBI, and GO)

Protein O43526 (Reactome details) participates in the following event(s):

R-HSA-373739 Ankyrins link voltage-gated sodium and potassium channels to spectrin and L1
R-HSA-1296127 Activation of voltage gated Potassium channels
R-HSA-445095 Interaction between L1 and Ankyrins
R-HSA-373760 L1CAM interactions
R-HSA-422475 Axon guidance
R-HSA-1296072 Voltage gated Potassium channels
R-HSA-1266738 Developmental Biology
R-HSA-1296071 Potassium Channels
R-HSA-112316 Neuronal System

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000359125.1, ENST00000359125.2, ENST00000359125.3, ENST00000359125.4, ENST00000359125.5, ENST00000359125.6, KCNQ2 , KCNQ2_HUMAN, NM_172107, O43526, O43796, O75580, O95845, Q4VXP4, Q4VXR6, Q5VYT8, Q96J59, Q99454, uc318awx.1, uc318awx.2
UCSC ID: ENST00000359125.7_10
RefSeq Accession: NM_172107.4
Protein: O43526 (aka KCNQ2_HUMAN or CIQ2_HUMAN)

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene KCNQ2:
bfns (KCNQ2-Related Disorders)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.